Craft

Isoray

Stock Price

$11.9

2024-10-29

Market Capitalization

$803.1 M

2024-10-29

Revenue

$1.4 M

FY, 2023

Isoray Summary

Company Summary

Overview
IsoRay Inc. is a national isotope-based medical company. With its patented radioisotope technology, the Company offers products including Cesium-131 seeds and other relevant treatment medicine for cancer and other malignant diseases. Its subsidiary, IsoRay Medical Inc., is the sole producer of Cesium-131 brachytherapy seeds. Brachytheraphy is when cancer-fighting medical radioisotopes are implanted in or around the affected tissue so to be as close to cancer as possible.
Type
Public
Status
Active
Founded
1998
HQ
Richland, WA, US | view all locations
Website
https://isoray.com/
Cybersecurity rating
Sectors

Key People

  • Lori A. Woods

    Lori A. Woods, CEO & Member of the Board of Directors

  • Jonathan Hunt
  • Alan Hoffmann

    Alan Hoffmann, Director

    • Jennifer Streeter

      Jennifer Streeter, COO & VP, Human Resources

    LocationsView all

    1 location detected

    • Richland, WA HQ

      United States

      350 Hills St #106

    Isoray Financials

    Summary Financials

    Net income (Q1, 2026)
    ($26.2M)
    Cash (Q1, 2026)
    $54.0M
    EBIT (Q1, 2026)
    ($28.3M)
    Enterprise value
    $777.4M

    Footer menu